California Code of Regulations
Title 17 - Public Health
Division 4 - California Institute for Regenerative Medicine
Chapter 2 - Scientific and Medical Accountability Standards
Section 100090 - Special Considerations for CIRM-Funded Procurement, Derivation and Transplantation
Current through Register 2024 Notice Reg. No. 12, March 22, 2024
(a) Where CIRM funds are to be used for research intended to derive a covered stem cell line, the SCRO committee must determine or the designated institutional official must certify the applicable requirements of Code of California Regulations, title 17, section 100080, subdivision (a)(2) or (a)(3), have been met subject to the following:
(b) CIRM funds may not be use to provide valuable consideration to donors of gametes, embryos, somatic cells or tissue. This provision does not prohibit reimbursement for permissible expenses as defined in California Code of Regulations, title 17, section 100200, subdivision (h).
(c) The modification of an acceptably derived stem cell line shall not be considered a CIRM-funded derivation.
1. New section
filed 10-10-2006; operative 11-22-2006 (Register 2006, No. 41).
2.
Repealer and new section filed 5-30-2008; operative 6-29-2008 (Register 2008,
No. 22).
3. Amendment of section heading and subsection (a), new
subsections (a)(1)-(4) and repealer and new subsection (b) filed 6-29-2010;
operative 7-29-2010 (Register 2010, No. 27).
Note: Authority cited: Article XXXV, California Constitution; and Section 125290.40(j), Health and Safety Code. Reference: Sections 125290.35, 125290.40 and 125290.55, Health and Safety Code.